![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessStatins and prostate cancer—hype or hope? The epidemiological perspective
Men using cholesterol-lowering statin medications have been found to have lower risks of both advanced and fatal prostate cancer in multiple registry-based studies and prospective cohort studies. Statin use ha...
-
Article
Open AccessAZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer
The transcript encoding Antizyme Inhibitor 1 (AZIN1) is frequently edited in various cancers, and this editing is associated with enhanced tumor aggressiveness. After comparison of wild-type AZIN1 (wtAZIN1) an...
-
Article
In search of the optimal setting for statin trials in prostate cancer: the power of population-based studies
-
Article
Open AccessThe association of diabetes with risk of prostate cancer defined by clinical and molecular features
To prospectively examine the association between diabetes and risk of prostate cancer defined by clinical and molecular features.
-
Article
Open AccessPsoriasin, a novel anti-Candida albicans adhesin
Candida albicans belongs to the normal microbial flora on epithelial surfaces of humans. However, under certain, still not fully understood conditions, it can become pathogenic and cause a spectrum of diseases, f...